BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 12534292)

  • 21. 1,2-GG intrastrand cross-link of antitumor dinuclear bifunctional platinum compound with spermidine linker inhibits DNA polymerization more effectively than the cross-link of conventional cisplatin.
    Moriarity B; Nováková O; Farrell N; Brabec V; Kaspárková J
    Arch Biochem Biophys; 2007 Mar; 459(2):264-72. PubMed ID: 17224122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+.
    Nováková O; Malina J; Kaspárková J; Halámiková A; Bernard V; Intini F; Natile G; Brabec V
    Chemistry; 2009 Jun; 15(25):6211-21. PubMed ID: 19449361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.
    Ramos-Lima FJ; Vrána O; Quiroga AG; Navarro-Ranninger C; Halámiková A; Rybnícková H; Hejmalová L; Brabec V
    J Med Chem; 2006 Apr; 49(8):2640-51. PubMed ID: 16610807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
    Wang D; Hara R; Singh G; Sancar A; Lippard SJ
    Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
    Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG
    J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal behavior of DNA thermal stability in the presence of platinum compounds. Role of monofunctional and bifunctional adducts.
    Lando DY; Galyuk EN; Chang CL; Hu CK
    J Inorg Biochem; 2012 Dec; 117():164-70. PubMed ID: 23085597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
    Boccarelli A; Coluccia M; Intini FP; Natile G; Locker D; Leng M
    Anticancer Drug Des; 1999 Jun; 14(3):253-64. PubMed ID: 10500500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
    Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
    Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
    Gelasco A; Lippard SJ
    Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC; van Dijk M; Lohman PH
    Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energetics, conformation, and recognition of DNA duplexes modified by monodentate Ru(II) complexes containing terphenyl arenes.
    Novakova O; Malina J; Suchankova T; Kasparkova J; Bugarcic T; Sadler PJ; Brabec V
    Chemistry; 2010 May; 16(19):5744-54. PubMed ID: 20376825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy of DNA modified by intrastrand cross-links of antitumor cisplatin.
    Vrána O; Masek V; Drazan V; Brabec V
    J Struct Biol; 2007 Jul; 159(1):1-8. PubMed ID: 17321149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
    Brabec V; Neplechova K; Kasparkova J; Farrell N
    J Biol Inorg Chem; 2000 Jun; 5(3):364-8. PubMed ID: 10907747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers.
    Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V
    Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex.
    Stehlíková K; Kaspárková J; Nováková O; Martínez A; Moreno V; Brabec V
    FEBS J; 2006 Jan; 273(2):301-14. PubMed ID: 16403018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N; Kelland LR; Roberts JD; Van Beusichem M
    Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.